Replies to post #78503 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

So it's pay to access... and that's why the company 8K'd it.

Note article titles:

High Risk and High Growth Potential in Small-Cap Life Sciences Space
Jay Albany
Investing in Best-in-Class Emerging Pharmaceuticals
Liana Moussatos



https://www.twst.com/